Distribution of exogenous metallothionein following intraperitoneal and intramuscular injection of metallothionein-deficient mice

Histology and Histopathology

Volumn 27, Issue 11, 2012, Pages 1459-1470

  Lewis, Katherine E ^a   Chung, Roger S ^a   West, Adrian K ^a   Chuah, Meng Inn ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Brain; Liver; MT I II knockout mice; MT IIA injection; Urinary system

Indexed keywords

METALLOTHIONEIN;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; DRUG EFFECT; GENETICS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; KNOCKOUT MOUSE; METABOLISM; MOUSE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; KIDNEY; METALLOTHIONEIN; MICE; MICE, KNOCKOUT;

MUS;

EID: 84869404121     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Abel J. and de Ruiter N. (1989). Inhibition of hydroxyl-radical-generated DNA degradation by metallothionein. Toxicol. Lett. 47, 191-196.
2. Ambjorn M., Asmussen J.W., Lindstam M., Gotfryd K., Jacobsen C., Kiselyov V.V., Moestrup S.K., Penkowa M., Bock E. and Berezin V. (2008). Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J. Neurochem. 104, 21-37.
3. Asmussen J.W., Ambjorn M., Bock E. and Berezin V. (2009a). Peptides modeled after the alpha-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons. Eur. J. Cell Biol. 88, 433-443.
4. Asmussen J.W., Von Sperling M.L. and Penkowa M. (2009b). Intraneuronal signaling pathways of metallothionein. J. Neurosci. Res. 87, 2926-2936.
5. Campagne M.v.L., Thibodeaux H., van Bruggen N., Cairns B., Gerlai R., Palmer J.T., Williams S.P. and Lowe D.G. (1999). Evidence for a protective role of metallothionein-1 in focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 96, 12870-12875.
6. Carro E., Spuch C., Trejo J.L., Antequera D. and Torres-Aleman I. (2005). Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor 1. Neurobiol. Dis. 25, 10884-10893.
7. Christensen E.I. and Nielsen S. (1991). Structural and functional features of protein handling in the renal proximal tubule. In: Seminars in Nephrology. Tisher C. and Madsen W. (eds). WB Saunders Co. Philadelphia. pp. 414-439.
8. Christensen E.I., Birn H., Verroust P. and Moestrup S.K. (1998). Membrane receptors for endocytosis in the renal proximal tubule. Int. Rev. Cytol. 180, 237-284.
9. Chung R.S., Vickers J.C., Chuah M.I. and West A.K. (2003). Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury. J. Neurosci. 23, 3336-3342.
10. Chung R.S., Adlard P.A., Dittmann J., Vickers J.C., Chuah M.I. and West A.K. (2004). Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J. Neurochem. 88, 454-461.
11. Chung R.S., Penkowa M., Dittmann J., King C.E., Bartlett C., Asmussen J.W., Hidalgo J., Carrasco J., Leung Y.K., Walker A.K., Fung S.J., Dunlop S.A., Fitzgerald M., Beazley L.D., Chuah M.I., Vickers J.C. and West A.K. (2008). Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury. J. Biol. Chem. 283, 15349-15358.
12. Clapp W.L., Madsen K.M., Verlander J.W. and Tisher C.C. (1987). Intercalated cells of the rat inner medullary collecting duct. Kidney Int. 31, 1080-1087.
13. Cousins R.J. and Leinart A.S. (1988). Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J. 2, 2884-2890.
14. Dehouck B., Fenart L., Dehouck M.-P., Pierce A., Torpier G. and Cecchelli R. (1997). A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 138, 877-889.
15. Ebadi M. and Sharma S. (2006). Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Exp. Biol. Med. 231, 1576-1583.
16. Feng W., Benz F.W., Cai J., Pierce W.M. and Kang Y.J. (2006). Metallothionein disulfides are present in metallothioneinoverexpressing transgenic mouse heart and increase under conditions of oxidative stress. J. Biol. Chem. 281, 681-687.
17. Fitzgerald M., Nairn P., Bartlett C.A., Chung R.S., West A.K. and Beazley L.D. (2007). Metallothionein-IIA promotes neurite growth via the megalin receptor. Exp. Brain Res. 183, 171-180.
18. Foulkes E.C. (1978). Renal tubular transport of cadmiummetallothionein. Toxicol. Appl. Pharmacol. 45, 505-512.
19. Giralt M., Penkowa M., Lago N., Molinero A. and Hidalgo J. (2002a). Metallothionein-1+2 protect the CNS after a focal brain injury. Exp. Neurol. 173, 114-128.
20. Giralt M., Penkowa M., Hernandez J., Molinero A., Carrasco J., Lago N., Camats J., Campbell I. and Hidalgo J. (2002b). Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6. Neurobiol. Dis. 9, 319-338.
21. Hamer D.H. (1986). Metallothionein. Annu. Rev. Biochem. 55, 913-951.
22. Hidalgo J., Penkowa M., Espejo C., Martinez-Caceres E.M., Carrasco J., Quintana A., Molinero A., Florit S., Giralt M. and Ortega-Aznar A. (2006). Expression of metallothionein-I,-II, and-III in Alzheimer disease and animal models of neuroinflammation. Exp. Biol. Med. 231, 1450-1458.
23. Kagi J.H. and Vallee B.L. (1960). Metallothionein: a cadmium-and zinccontaining protein from equine renal cortex. J. Biol. Chem. 235, 3460-3465.
24. Kang Y.J., Li G. and Saari J.T. (1999). Metallothionein inhibits ischemiareperfusion injury in mouse heart. Am. J. Physiol. 276, H993-997.
25. Kierszenbaum A.L. (2007). Histology and cell biology: an introduction to pathology, 2 ed. Mosby Elsevier. Philadelphia.
26. Klassen R.B., Crenshaw K., Kozyraki R., Verroust P.J., Tio L., Atrian S., Allen P.L. and Hammond T.G. (2004). Megalin mediates renal uptake of heavy metal metallothionein complexes. Am. J. Physiol. 287, F393-F403.
27. Klassen R.B., Allen P.L., Batuman V., Crenshaw K. and Hammond T.G. (2005). Light chains are a ligand for megalin. J. Appl. Physiol. 98, 257-263.
28. Leheste J.-R., Rolinski B., Vorum H., Hilpert J., Nykjaer A., Jacobsen C., Aucouturier P., Moskaug J.O., Otto A., Christensen E.I. and Willnow T.E. (1999). Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 155, 1361-1370.
29. Marino M., Andrews D., Brown D. and McCluskey R.T. (2001). Transcytosis of retinol-binding protein across the renal proximal tubule cells after megalin (gp 330)-mediated endocytosis. J. Am. Soc. Nephrol. 12, 637-648.
30. Masters B.A., Kelly E.J., Quaife C.J., Brinster R.L. and Palmiter R.D. (1994). Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA 91, 584-588.
31. Michalska A.E. and Choo K.H.A. (1993). Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. USA 90, 8808-8092.
32. Nagano S., Satoh M., Sumi H., Fujimura H., Tohyama C., Yanagihara T. and Sakoda S. (2001). Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur. J. Neurosci. 13, 1363-1370.
33. Nilsson S.K., Christensen S., Raarup M.K., Ryan R.O., Nielsen M.S. and Olivecrona G. (2008). Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. J. Biol. Chem. 283, 25920-25927.
34. Penkowa M. and Hidalgo J. (2000). Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia 32, 247-263.
35. Penkowa M., Carrasco J., Giralt M., Moos T. and Hidalgo J. (1999). CNS wound healing is severely depressed in metallothionein I-and II-deficient mice. J. Neurosci. 19, 2535-2545.
36. Richards R.I., Heguy A. and Karin M. (1984). Structural and functional analysis of the human metallothionein-Ia gene: differential induction by metal ions and glucocorticoids. Cell 37, 263-272.
37. Riedel I.B., Hermans-Borgmeyer I. and Hubner C.A. (2002). SorLA, a member of the LDL receptor family, is expressed in the collecting duct of the murine kidney. Histochem. Cell Biol. 118, 183-191.
38. Sonn K., Pankratova S., Korshunova I., Zharkovsky A., Bock E., Berezin V. and Kiryushko D. (2010). A metallothionein mimetic peptide protects neurons against kainic acid-induced excitotoxicity. J. Neurosci. Res. 88, 1074-1082.
39. Spoeglen R., Adams K.W., Koker M., Thomas A.V., Andersen O.M., Hallett P.J., Bercury K.K., Joyner D.F., Deng M., Stoothoff W.H., Strickland D.K., Willnow T.E. and Hyman B.T. (2009). Interaction of the apolipoprotein E receptors low density lipoprotein receptorrelated protein and sorLA/LR11. Neuroscience 158, 1460-1468.
40. Thornalley P.J. and Vasák M. (1985). Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta 827, 36-44.
41. Trendelenburg G., Prass K., Priller J., Kapinya K., Polley A., Muselmann C., Ruscher K., Kannbley U., Schmitt A.O., Castell S., Wiegand F., Meisel A., Rosenthal A. and Dirnagl U. (2002). Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22, 5879-5888.
42. Verroust P.J. and Christensen E.I. (2002). Megalin and cubilin-the story of two multipurpose receptors unfolds. Nephrol. Dial. Transplant. 17, 1867-1871.
43. Wolff N.A., Abouhamed M., Verroust P.J. and Thevenod F. (2006). Megalin-dependent internalization of cadmium-metallothionein and cytotoxicity in cultured renal proximal tubule cells. J. Pharmacol. Exp. Ther. 318, 782-791.
44. Wu D. and Pardridge W.M. (1999). Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc. Natl. Acad. Sci. USA 96, 254-259.
45. Zheng G., Bachinsky D.R., Stamenkovic I., Strickland D.K., Brown D., Andres G. and McCluskey R.T. (1994). Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42, 531.
46. Zlokovic B.V., Martel C.L., Matsubara E., McComb J.G., Zheng G., McCluskey R.T., Frangione B. and Ghiso J. (1996). Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid ' at the blood-brain and blood-cerebrospinal fluid barriers Proc. Natl. Acad. Sci. USA 93, 4229-4234.